Posts Archive


Patents in the Crosshairs During House Drug Pricing Debate

The opening salvo in what promises to be one of the hottest debates in the new Congress was fired January 29 during a day-long hearing in the House …
By Joseph Allen
14 days ago 24

Bioinformatics Innovations Thrive Despite 101 Chaos

Bioinformatics is a growing interdisciplinary technological field in which computing and software resources are applied to biological data and solve biological problems. For example, bioinformatics can be …
By Kate Gaudry & Samuel Hayim
14 days ago 3

Federal Circuit Affirms Eastern District of Texas Holding that Medtronic Induced Infringement of Doctor’s Patents

On January 24, the Federal Circuit affirmed a jury’s finding that the defendant-appellant, Medtronic, induced surgeons to infringe two patents of plaintiff-appellee, Dr. Mark Barry, which were …

Why Helsinn v. Teva Creates Inscrutable Uncertainty About the Scope of Prior Art Instead of Confirming Longstanding Law

To the casual observer, the Supreme Court’s January 23 decision in Helsinn v. Teva may seem like no big deal. In just a few pages of text, …
By Hans Sauer
15 days ago 15

Gene Quinn Joins Berenato & White But Remains President and CEO at IPWatchdog

I am pleased to announce that effective February 1, 2019, I have become Of Counsel to the law firm of Berenato & White, LLC. The firm is located in suburban …
By Gene Quinn
15 days ago 11

Letter Signed By 170 Corporate Counsel Urges Law Firms to Get Diverse Fast

On January 27, more than 170 general counsel and corporate legal executives signed an open letter to big law firms expressing their disappointment that “many law firms continue to …
By Amanda G. Ciccatelli
15 days ago 5

Federal Circuit Rule 36 Judgment in VirnetX v. Cisco and Apple: A Look at the Oral Arguments

IPWatchdog has been closely following the growing trend of Rule 36 affirmances at the Federal Circuit. Perhaps one of the most widely publicized of these was the January 15 …
By Steve Brachmann
15 days ago 8

Standard Essential Patents: The Myths and Realities of Standard Implementation

Standard Essential Patents (SEPs) are patents that are unavoidable for the implementation of a standardized technology. They represent core, pioneering innovation that entire industries will build upon. …
By Gene Quinn
16 days ago 6

IP and Innovation on Capitol Hill: Week of February 4

This week on Capitol Hill, committee hearings in the U.S. Senate will focus on innovations related to financial systems, the race to 5G network connectivity and …
By IPWatchdog
16 days ago 1

Freedom to Operate and the Interplay of Patent and Regulatory Exclusivity for Life Sciences

While part one of this two-part series on intellectual property (IP) due diligence focused on a life science company’s own IP portfolio, part two will address …

Closing the Gap Between Intellectual Property Awareness and Understanding

Intellectual property (IP) promotes innovation. The limited right to exclude others from copying patented inventions, copyrighted original works of authorship, and trademarked brands and logos encourages innovators …
By Manny Schecter
17 days ago 16

No License No Cry: Ninth Circuit Nixes Jammin Java Appeal in Bob Marley Trademark Case

Early last month, the U.S. Court of Appeals for the Ninth Circuit issued a memorandum affirming the district court’s grant of partial summary judgment in …
By Steve Brachmann
18 days ago 2

Other Barks & Bites: IP News to Watch, February 1, 2019

This week in Other Barks & Bites: Huawei is in hot water with both the U.S. and UK governments, while Qualcomm has just completed a new patent …

IP Due Diligence in the Life Sciences: Key Considerations for 2019

The success of a life science product, and thereby the company, rests heavily upon a combination of patent protection, regulatory exclusivity and product life cycle management. A …

District of Delaware Makes it Harder to Corner the Market on Antibody Patents in MorphoSys v. Janssen

Patents covering an antibody are often claimed by the antibody’s function (the residues where it binds to the antigen) rather than its structure (amino-acid sequence). This …
By Zachary Silbersher
20 days ago 2